1. 994OLenvatinib (LEN) and pembrolizumab (PEMBRO) in advanced endometrial cancer (EC). (1st October 2019) Authors: Makker, V; Taylor, M H; Aghajanian, C; Oaknin, A; Mier, J; Cohn, A L; Marin, M Romeo; Lorenzo, R Bratos; Brose, M S; DiSimone, C; Messing, M J; Stepan, D E; Dutcus, C E; Wu, J; Schmidt, E V; Orlowski, R J; Sachdev, P; Shumaker, R; Herraez, A Casado Journal: Annals of oncology Issue: Volume 30(2019)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗